Shabana Usman Simjee

Prof. Dr. Shabana Usman Simjee


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017
Verified
Journal Article
Open access
PDF file
FHFarina Hanif
Farina Hanif
KMKanza Muzaffar
Kanza Muzaffar
KPKahkashan Perveen
Kahkashan Perveen
SMSaima Mehmood Malhi
Saima Mehmood Malhi
SSShabana Usman Simjee
Shabana Usman Simjee
Glioblastoma multiforme (GBM) is one of the most malignant types of central nervous system tumors. Despite advances in treatment modalities it remains largely incurable. The objective of our review is to provide a holistic picture of GBM epidemiology, etiology, pathogenesis, clinical findings and treatment. A literature search was conducted for GBM at PubMed and Google Scholar, with relevant key words like glioblastoma multiforme, pathogenesis, signs and symptoms, treatment etc., and papers published until 2015 were reviewed. It was found that radiation and certain genetic syndromes are the only risk factors identified to date for GBM. Depending on the tumor site patients may present to the clinic with varying symptoms. To confirm the presence and the extent of tumor, various invasive and non-invasive imaging techniques require employment. The literature survey revealed the pathogenesis to involve aberrations of multiple signaling pathways through multiple genetic mutations and altered gene expression. Although several treatment options are available, including surgery, along with adjuvant chemo- and radio-therapy, the disease has a poor prognosis and patients generally succumb within 14 months of diagnosis.

1 June 2018 in International Immunopharmacology
Verified
Journal Article
Closed access
AGAnum Gul
Anum Gul
BKBimal Kunwar
Bimal Kunwar
MMMaryam Mazhar
Maryam Mazhar
SFShaheen Faizi
Shaheen Faizi
DADania Ahmed
Dania Ahmed
SSShabana Usman Simjee
Shabana Usman Simjee

1 March 2008 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
MNMuhammad Nisar
Muhammad Nisar
IKInamullah Khan
Inamullah Khan
SSShabana Usman Simjee
Shabana Usman Simjee
AGAnwarul-Hassan Gilani
Anwarul-Hassan Gilani
OBObaidullah
Obaidullah
HPHumera Perveen
Humera Perveen

15 February 2017 in BMC Complementary and Alternative Medicine
Verified
Journal Article
Open access
PDF file
MMMarius Mbiantcha
Marius Mbiantcha
JAJabeen Almas
Jabeen Almas
SSShabana Usman Simjee
Shabana Usman Simjee
DNDastagir Nida
Dastagir Nida
FAFaheem Aisha
Faheem Aisha
Rheumatoid arthritis, disease of unknown causes is a rheumatic and autoimmune pathology, recognised for its increasing frequency and its adverse consequences. It is a disease that occurs in most cases between 50 and 60 years and women are more affected than men. This study aimed at evaluating immunomodulatory and anti-arthritis capacity of aqueous and methanol extracts of stem bark of Piptadeniastrum africanum (Mimosaceae). ROS production from phagocytes, proliferation of T-cells, TNF-α and IL-1β production and cytotoxicity were performed by using chemiluminescence technique, liquid scintillation counter, ELISA and MTT assay, respectively. Anti-arthritic activity was evaluated using a model of adjuvant induced arthritis. Methanol and aqueous extracts of Piptadeniastrum africanum significantly (P < 0.001) inhibited extracellular and intracellular ROS production. These extracts also possess significant (P < 0.001) inhibitory activity on T-cell proliferation other than reduced TNF-α and IL-1β production. Piptadeniastrum africanum also significantly exhibited antiarthritic activity in complete Freund’s adjuvant induced arthritis in rat associated with a significant anti-inflammatory and anti-hyperalgesia activity. Immunomodulatory, anti-inflammatory, antihyperalgesia and anti-arthritis potential revealed in this study approve that, Piptadeniastrum africanum is a plant rich in compounds with anti-arthritic properties.

1 August 2010 in International Immunopharmacology
Verified
Journal Article
Closed access
HJHuma Jawed
Huma Jawed
SSSyed Uzair Ali Shah
Syed Uzair Ali Shah
SJSiddiqua Jamall
Siddiqua Jamall
SSShabana Usman Simjee
Shabana Usman Simjee

1 July 2016 in International Immunopharmacology
Verified
Journal Article
Closed access
AJAlmas Jabeen
Almas Jabeen
MMM. Ahmad Mesaik
M. Ahmad Mesaik
SSShabana Usman Simjee
Shabana Usman Simjee
LULubna
Lubna
SBSamina Bano
Samina Bano
SFShaheen Faizi
Shaheen Faizi